Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer.
Saved in:
| Title: | Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer. |
|---|---|
| Authors: | Zhang S; Department of Urology, Lanzhou University Second Hospital, Lanzhou, China., Zhang H; Cuiying Honors College, Lanzhou University, Lanzhou, China., Dong X; Department of Urology, Gannan Tibetan Autonomous Prefecture People's Hospital, Hezuo, China., Qi Z; Department of Urology, Gannan Tibetan Autonomous Prefecture People's Hospital, Hezuo, China., Ma Y; Department of Urology, Gannan Tibetan Autonomous Prefecture People's Hospital, Hezuo, China., Chang H; Department of Urology, Lanzhou University Second Hospital, Lanzhou, China., Li Y; Department of Urology, Lanzhou University Second Hospital, Lanzhou, China., Zhang W; Department of Urology, Gannan Tibetan Autonomous Prefecture People's Hospital, Hezuo, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 08; Vol. 17, pp. 1866469. Date of Electronic Publication: 2026 Jun 08 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1866469 |
